Treatment

Pamorelin® LA 3 clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic exploratory (Phase II)
IBCSG 67-22 PREcoopERA: A Window-of-Opportunity trial of giredestrant +/- triptorelin vs. anastrozole + triptorelin in premenopausal patients with ER-positive/HER2-negative early breast cancer.
This study looks at new ways to treat early breast cancer in women before menopause. It compares different hormone treatments to see which best slows down cancer cell growth, using medicines like giredestrant, triptorelin, and anastrozole. The aim is to find more effective options for this type of breast cancer.
For: ER-positive/HER2-negative early breast cancer
Spain · Germany · Italy